0001437749-22-014039.txt : 20220601 0001437749-22-014039.hdr.sgml : 20220601 20220601163214 ACCESSION NUMBER: 0001437749-22-014039 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220531 FILED AS OF DATE: 20220601 DATE AS OF CHANGE: 20220601 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bhalla Amit CENTRAL INDEX KEY: 0001861065 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35076 FILM NUMBER: 22987835 MAIL ADDRESS: STREET 1: 4995 BRADENTON AVE STREET 2: SUITE 240 CITY: DUBLIN STATE: OH ZIP: 43017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NAVIDEA BIOPHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000810509 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 311080091 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4995 BRADENTON AVENUE STREET 2: SUITE 240 CITY: DUBLIN STATE: OH ZIP: 43017 BUSINESS PHONE: 6147937500 MAIL ADDRESS: STREET 1: 4995 BRADENTON AVENUE STREET 2: SUITE 240 CITY: DUBLIN STATE: OH ZIP: 43017 FORMER COMPANY: FORMER CONFORMED NAME: NEOPROBE CORP DATE OF NAME CHANGE: 19940714 4 1 rdgdoc.xml FORM 4 X0306 4 2022-05-31 0000810509 NAVIDEA BIOPHARMACEUTICALS, INC. NAVB 0001861065 Bhalla Amit 4995 BRADENTON AVE., SUITE 240 DUBLIN OH 43017 1 Common Stock 2022-05-31 4 A 0 2500 0 A 58068 D Stock issued under the Amended and Restated 2014 Stock Incentive Plan in partial payment of monthly non-employee director fees. Issuance deferred at the request of the Reporting Person. /s/ Erika L. Eves for Amit Bhalla, by power of attorney 2022-06-01